PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'The Institute for Therapeutic Discovery, Delanson, New York, USA.\', \'The Ohio State University, Columbus, Ohio, USA.\', \'The University of Kentucky, Lexington, Kentucky, USA.\', \'Yale University, New Haven, Connecticut, USA.\', \'The University of North Carolina-Wilmington, Wilmington, North Carolina, USA.\', \'Brown University, Providence, Rhode Island, USA.\', \'Sandy Hook Clinic, Sandy Hook, Connecticut, USA.\', \'CMC Biosciences, Beverly, Massachusetts, USA.\', \'Beech Tree Labs, Providence, Rhode Island, USA.\', \'The Institute for Therapeutic Discovery, Delanson, New York, USA jm@beechtreelabs.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • e00288-2010.1128/mSphere.00288-20
?:doi
?:hasPublicationType
?:journal
  • mSphere
is ?:pmid of
?:pmid
?:pmid
  • 32404512
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.03
?:rankingScore_hIndex
  • 12
is ?:relation_isRelatedTo_publication of
?:title
  • Can Unconventional Immunomodulatory Agents Help Alleviate COVID-19 Symptoms and Severity?
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all